Cystic Fibrosis Foundation expands partnership with Pfizer

11/20/2012 | Genetic Engineering & Biotechnology News

The Cystic Fibrosis Foundation committed up to $58 million over six years in a project with Pfizer to develop drugs targeting the Delta F508 genetic mutation associated with the disease. The CFF retains rights to any drug candidate Pfizer discovers but chooses not to develop.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA